1. 618OHealth-related quality of Life (HRQOL) and disease symptoms in patients with unresectable hepatocellular carcinoma (HCC) treated with lenvatinib (LEN) or sorafenib (SOR). (18th September 2017) Authors: Vogel, A.; Qin, S.; Kudo, M.; Hudgens, S.; Yamashita, T.; Yoon, J-H.; Fartoux, L.; Simon, K.; López López, C.; Sung, M.; Dutcus, C.; Kraljevic, S.; Tamai, T.; Grunow, N.; Meier, G.; Breder, V. Journal: Annals of oncology Issue: Volume 28(2017)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗